Xilio Therapeutics XLO Balance Sheet (2020-2026)

NASDAQ XLO
$9.23 -0.18 (-1.91%)
At close: Aug 20, 2026 · 4:00 PM EDT
Balance Sheet Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)
99.77M198.05M176.96M159.41M139.14M120.39M93.27M75.38M59.77M44.70M33.98M74.95M61.26M55.29M89.07M121.55M103.76M137.53M150.30M136.04M
Cash & Current Investments (Quarter)
99.77M198.05M176.96M159.41M139.14M120.39M93.27M75.38M59.77M44.70M33.98M74.95M61.26M55.29M89.07M121.55M103.76M137.53M150.30M136.04M
Receivables - Net (Quarter)
30.00M
Receivables (Quarter)
30.00M
Prepaid Assets (Quarter)
2.41M4.46M4.13M3.60M3.17M4.11M3.71M3.04M4.71M3.42M5.21M3.06M2.05M4.94M4.13M2.17M2.83M2.50M3.87M3.43M
Current Assets (Quarter)
105.57M202.52M181.09M163.01M142.31M124.50M96.98M78.42M64.48M48.13M69.19M78.01M63.31M60.23M93.20M123.72M124.09M145.03M154.21M145.47M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
7.11M7.62M7.47M7.44M7.55M7.25M7.25M6.80M6.37M5.94M5.54M5.14M4.84M4.47M4.29M4.02M3.68M3.89M3.68M3.36M
Other Non-Current Assets (Quarter)
1.55M0.39M1.55M1.55M1.56M0.27M1.57M0.20M0.17M0.14M2.76M0.09M1.77M1.78M1.79M1.79M1.80M1.81M1.81M1.82M
Non-Current Assets (Quarter)
15.15M15.54M15.27M15.12M15.10M14.67M14.53M13.93M13.36M12.80M13.42M11.87M11.35M10.84M10.52M10.10M9.61M9.66M9.28M8.79M
Assets (Quarter)
120.72M218.06M196.35M178.13M157.41M139.16M111.50M92.36M77.84M60.93M82.61M89.87M74.66M71.08M103.72M133.81M133.69M154.69M163.49M154.25M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
3.82M3.14M2.32M1.41M1.81M3.12M2.01M0.94M1.49M1.05M0.75M1.26M0.97M2.57M2.27M4.10M2.30M3.17M1.06M2.31M
Notes Payables (Quarter)
1.67M3.33M5.00M6.67M6.67M7.14M4.96M3.31M
Payables (Quarter)
3.82M3.14M3.99M4.74M6.81M9.79M8.68M8.09M6.44M4.37M0.75M1.26M0.97M2.57M2.27M4.10M2.30M3.17M1.06M2.31M
Accumulated Expenses (Quarter)
8.19M8.75M7.32M12.09M9.06M10.33M6.48M7.14M9.40M10.50M8.00M9.74M0.01M9.98M3.88M5.62M8.95M11.74M8.97M7.85M
Other Accumulated Expenses (Quarter)
0.08M0.32M0.19M0.30M0.08M0.08M0.27M0.08M0.07M0.05M0.11M0.01M0.14M0.13M0.17M0.20M0.09M0.08M0.20M0.09M
Current Leases (Quarter)
0.77M0.80M0.83M0.86M0.89M0.92M0.95M0.98M1.01M1.05M1.08M1.12M1.15M1.19M1.23M1.26M1.30M1.34M1.38M1.43M
Current Deferred Revenue (Quarter)
21.73M26.52M26.11M13.52M78.99M42.28M69.34M40.02M31.54M35.32M
Total Current Liabilities (Quarter)
12.87M12.78M12.22M17.77M16.84M21.12M16.19M16.29M16.93M15.96M31.58M38.64M38.02M27.26M47.64M53.26M56.40M56.27M42.96M34.20M
Non-Current Liabilities
Non-Current Debt (Quarter)
9.58M9.63M8.01M6.39M4.78M3.17M1.55M
Non-Current Deffered Revenue (Quarter)
17.40M10.25M8.40M19.26M38.74M28.63M25.50M20.64M16.47M12.71M
Preferred Stock Liabilities (Quarter)
100.15M
Operating Leases (Quarter)
10.32M10.11M9.89M9.66M9.43M9.19M8.95M8.68M8.41M8.14M7.86M7.57M7.26M6.95M6.64M6.30M5.96M5.61M5.25M4.88M
Other Non-Current Liabilities (Quarter)
1.52M0.12M0.10M0.08M0.06M0.04M0.03M0.01M38.55M53.93M29.56M26.26M30.20M
Total Non-Current Liabilities (Quarter)
32.77M32.51M30.13M33.83M31.05M33.47M26.69M24.98M88.19M87.86M89.85M64.68M51.79M
Total Liabilities (Quarter)
34.29M32.63M30.23M33.91M31.12M33.52M26.71M24.98M25.34M24.10M56.84M56.46M53.68M53.48M93.02M126.74M141.79M119.41M90.94M81.99M
Shareholder's Equity
Total Debt (Quarter)
9.58M9.63M8.01M6.39M4.78M3.17M1.55M
Common Equity (Quarter)
-136.46M185.43M166.12M144.22M126.30M105.65M84.79M67.38M52.50M36.83M25.77M33.42M20.97M17.60M10.70M7.07M-8.10M35.27M72.55M72.26M
Liabilities and Shareholders Equity (Quarter)
120.72M218.06M196.35M178.13M157.41M139.16M111.50M92.36M77.84M60.93M82.61M89.87M74.66M71.08M103.72M133.81M133.69M154.69M163.49M154.25M
Retained Earnings (Quarter)
-141.19M346.31M-182.24M351.07M352.94M354.75M356.54M-291.11M-307.90M-325.51M-342.71M-356.60M-370.70M-383.75M-397.00M-412.90M-429.10M454.06M500.86M506.95M
Treasury Shares (Quarter)
68.27M0.11M0.10M0.08M0.06M0.05M0.03M0.02M0.01M0.01M0.48M0.45M0.45M0.03M0.33M0.33M0.33M0.02M0.02M0.01M